Add BrightSurf on Google Email

Brigham and Women's Hospital


Gene engineered cell therapy developed to target brain metastatic melanomas

Scientists from Brigham and Women's Hospital have developed a new immuno-therapeutic approach using twin stem cells that can target brain metastatic melanomas. The therapy, which uses an engineered 'twin stem cell model,' activates the immune system to suppress tumor growth and prolong survival in representative preclinical models.

SourceBrigham and Women's Hospital·JournalScience Translational Medicine·TypeExperimental study·DateMay 31, 2023

Study finds daily multivitamin supplements improved memory and slowed cognitive aging in older adults

A new study published in The American Journal of Clinical Nutrition found that daily multivitamin supplements improved memory and slowed cognitive aging in older adults. The COSMOS-Web trial included over 3,500 participants aged 60 and older who completed novel web-based assessments of memory and cognition annually for three years.

SourceBrigham and Women's Hospital·JournalAmerican Journal of Clinical Nutrition·DateMay 24, 2023

Ingestible electroceutical capsule shows promise for treating gastrointestinal conditions

Researchers from Brigham and Women's Hospital developed an ingestible capsule, known as the FLASH system, which electronically stimulates key hunger hormone ghrelin in pigs. The system has potential applications for treating gastrointestinal disorders and is a promising alternative to traditional treatments.

SourceBrigham and Women's Hospital·JournalScience Robotics·TypeObservational study·DateApr 26, 2023

Childhood abuse and biological sex linked to epigenetic changes in functional neurological disorder

A study by Brigham researchers reveals that childhood trauma and biological sex are associated with epigenetic changes in functional movement/conversion disorder. Female patients and those with an history of childhood trauma show distinct profiles of epigenetic changes linked to this condition.

SourceBrigham and Women's Hospital·JournalProgress in Neuro-Psychopharmacology and Biological Psychiatry·DateApr 19, 2023

Among untreated patients with COVID-19, combined symptom and viral rebound is rare

Researchers found that symptom and viral rebound are rare in untreated COVID-19 patients, with 26% experiencing symptom rebound and 31% experiencing viral rebound. However, short-term rebounds were common, and only a small percentage of participants experienced both symptom and high-level viral rebound.

SourceBrigham and Women's Hospital·JournalAnnals of Internal Medicine·TypeObservational study·DateApr 5, 2023

Genome-wide CRISPR screens identify PARP inhibitor sensitivity and resistance in prostate cancer

A recent study identified novel genes that influence PARP inhibitor response in prostate cancer, including MMS22L and RNASEH2B. The research found that loss of CHEK2, a previously approved biomarker, confers resistance to PARP inhibition, highlighting the need for comprehensive genomic analysis to improve treatment decisions.

SourceBrigham and Women's Hospital·JournalNature Communications·TypeExperimental study·DateApr 4, 2023

Racial health inequality in prostate cancer associated with facility-level disparities

A study found that facility-level disparities in the US are associated with poorer prostate cancer treatment and outcomes for racial minorities. Non-Hispanic black men treated at high-burden safety-net hospitals had the worst outcomes, highlighting the need for targeted initiatives to address these disparities.

SourceBrigham and Women's Hospital·JournalUrologic Oncology Seminars and Original Investigations·TypeData/statistical analysis·DateMar 13, 2023

First nasal monoclonal antibody treatment for COVID-19 shows promise for treating virus, other diseases

Researchers at Brigham and Women's Hospital tested a new nasal monoclonal antibody treatment, Foralumab, which decreased inflammatory markers and lung inflammation in patients with COVID-19. The treatment also showed similar effects in multiple sclerosis patients, suggesting its potential use for treating other diseases.

SourceBrigham and Women's Hospital·JournalProceedings of the National Academy of Sciences·TypeObservational study·DateMar 8, 2023

Consulting Dr. YouTube: How digital misinformation may keep you from a good night’s sleep

A Brigham and Women's Hospital study reveals that popular YouTube videos on sleep health often contain misinformation, despite expert-led content receiving significantly fewer views. The study highlights the prevalence of consumer bias in popular videos, which may lead to patients avoiding care or receiving wrong care.

SourceBrigham and Women's Hospital·JournalJournal of Clinical Sleep Medicine·DateFeb 27, 2023

Cystatin C shows promise as an additional biomarker to calculate kidney function and stage chronic kidney disease

A study found that cystatin C-based eGFR was strongly correlated with creatinine-based eGFR and that 27% of patients would be classified as having a more severe chronic kidney stage based on cystatin C test results. The use of cystatin C can lead to changes in CKD staging, which can impact clinical management.

SourceBrigham and Women's Hospital·JournalKidney Medicine·TypeObservational study·DateFeb 14, 2023

Dental service use falls, oral health worsens after people become eligible for Medicare

A recent study found that nearly half of older adults receive no dental care and half lack dental insurance. After becoming eligible for Medicare, the percentage of people receiving restorative dental care decreased by 8.7%, while complete edentulism increased by almost 5 percentage points among those aged 65 and above.

SourceBrigham and Women's Hospital·JournalHealth Affairs·TypeData/statistical analysis·DateFeb 7, 2023

Study suggests vitamin D benefits and metabolism may depend on body weight

Researchers analyzed data from the VITAL trial and found that vitamin D supplementation increased biomarkers associated with vitamin D metabolism in people, regardless of their weight. However, these increases were significantly smaller in people with elevated BMIs, suggesting a blunted response to supplementation.

SourceBrigham and Women's Hospital·JournalJournal of the American Medical Association·TypeObservational study·DateJan 17, 2023